Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer.

ABSTRACT:

Objective

To determine if laparoscopy is a cost-effective way to assess disease resectability in patients with newly diagnosed advanced ovarian cancer.

Methods

A cost-effectiveness analysis from a health care payer perspective was performed comparing two strategies: (1) a standard evaluation strategy, where a conventional approach to treatment planning was used to assign patients to either primary cytoreduction (PCS) or neoadjuvant chemotherapy with interval cytoreduction (NACT), and (2) a laparoscopy strategy, where patients considered candidates for PCS would undergo laparoscopy to triage between PCS or NACT based on the laparoscopy-predicted likelihood of complete gross resection. A microsimulation model was developed that included diagnostic work-up, surgical and adjuvan

SUBMITTER: Harrison RF 

PROVIDER: S-EPMC8247119 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature